Dubai, United Arab Emirates. - Wednesday, May 13th 2015 [ME NewsWire]
Dubai Biotechnology and Research Park (DuBiotech), a free zone dedicated to facilitating and fostering growth in the UAE’s life sciences industry, today announced that B.Braun, a German medical and pharmaceutical device firm, has established a Middle East operating subsidiary at the free zone business park.
B. Braun Medical Gulf will serve as a regional hub for its four divisions; B. Braun Hospital Care, B. Braun Aesculap, B. Braun OPM and B. Braun Avitum. From its new base at DuBiotech, B.Braun will now be able to offer a complete range of products and services for value retention of medical capital equipment, as well as provide planning and consulting services, training & education for the Gulf region.
B. Braun currently operates more than 50 companies around the world and is committed to increasing its global presence through organic growth.
Markus Strotmann, B.Braun CEO, commented: “One philosophy underpins everything we stand for at B.Braun and that is sharing expertise. This means that by sharing knowledge with our clients, B. Braun helps to improve therapies and procedures in hospitals and clinics to increase the safety of patients, doctors and nursing staff. This also helps drive innovation by exchanging knowledge with healthcare professionals and increasing efficiency with our expert employees worldwide.”
 “The Middle Eastern region has significant potential for developing a thriving health and life science sector. DuBiotech has established a vibrant community of like-minded life science professionals, which aids in the success of our objectives by providing health solutions. We’re very excited to be part of this.”
Marwan Abdulaziz, Executive Director of DuBiotech said: “The UAE’s healthcare sector has substantial growth potential and as a result, Dubai is well placed to evolve into an innovative regional hub for R&D investment for major market players. The UAE has an open door policy to attract foreign investment, and together with the UAE Government, DuBiotech is working towards facilitating synergies that favour innovation, growth and development.”
“Our aim is to develop relationships with the highest levels of Government and leading health industry representatives like B.Braun to drive the potential of the industry and ensure it is a major contributor to economic growth in the UAE.”
ENDS                                                               
Note to Editors:
About DuBiotech
Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments, is a free zone business park dedicated to fostering the growth of the life sciences industry in the region. DuBiotech was established to support the Government of Dubai’s vision to transform the UAE into a knowledge-based economy and develop the region’s talent pool.
DuBiotech offers world-class infrastructure and cutting edge research and development facilities, specifically designed and built for the field of biotechnology, pharmaceutical, medical and scientific device, food and agricultural industries. The free zone can support both start-ups and international firms looking for a regional base for their Middle East or global operations. The park is central to a community that is committed to the industry’s success by bringing together business, regulators and Government in partnership.
Since its launch in 2005, DuBiotech has rapidly grown into a community of more than195 life sciences companies such as Pfizer, Merck-Serono, Amgen, Bristol-Myers Squibb, Maquet, National Reference Lab, ThermoFisher, Bayer, Mylan, Firmenich and IFF.
For further information on DuBiotech, please visit our website: www.dubiotech.ae.
About B.Braun
B.Braun supplies the global healthcare market with products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery, as well as services for hospitals, general practitioners and the homecare sector.
Through dialogue with those who are using B.Braun’s products, the company is continually gaining new knowledge which it incorporates into product development. In this way, the company contributes with innovative products and services towards optimizing working procedures in hospitals and medical practices all over the world and improving safety – for patients, doctors and nursing staff.
For further information on B.Barun, please visit www.bbraun.com
Contacts
Iain Munro, Bell Pottinger;
 +971 55559 7389
 
 
 
 
Permalink: http://me-newswire.net/news/14575/en